Accounting for 12% of all cases, t(8; 21)(q22; q22.1) is a common chromosomal abnormality observed in AML patients that generates the RUNX1::ETO fusion oncogene [3] and has been associated with the downregulation of RUNX3 [4]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.